Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
批准号:
6692208
负责人:
Joseph Paul Konopelski
金额:
$26.43万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-01-01 至 2006-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The principle objectives of this research project are the synthesis, in enantiomerically pure form, of diazonamide A (revised structure, 1) and N-methylwelwitindolinone C isothiocyanate (2). The specific aims will focus on six challenges: 1. The first aim is an efficient synthesis of the desired stereochemistry at the C10/C11 centers as an advanced fragment leading to diazonamide A. Aryllead(IV) compounds are highly selective and mild reagents for the production of quaternary centers. Our studies in this area have been especially fruitful. 2. The second aim is the execution of an effective aryl-aryl coupling reaction to set the C16/C18 bond. Organometallic technology can be employed to perform this aryl-aryl coupling reaction. Many such examples exist in the literature, and our own studies concur with this assessment. 3. The third aim is the efficient synthesis of the bis-oxazole system in conjunction with generation of the macrobicyclic structure of diazonamide A. Cyclodehydration of a N-acyI-D-aminoketone will effectively generate the C29 through C31 oxazole, whereas the C26 through C28 chlorooxazole can be effectively prepared via a [3+2] cycloaddition strategy. 4. The fourth aim is the efficient synthesis of the entire ring system of N-methylwelwitindolinone C isothiocyanate. An intramolecular conjugate addition reaction between C3 and C16, coupled with an efficient intermolecular coupling of the indole C4 position with C11, will efficiently generate the central sevenmembered ring of 2. 5. The fifth aim is the successful synthesis of the C11/C12 array of stereocenters in Nmethylwelwitindolinone C isothiocyanate. Directed introduction of functionality at C12 from C11 will allow both centers to be developed simultaneously. 6. The sixth specific aim is the synthesis of selected derivatives of both these targets for biological testing and evaluation. Collaborations for testing have been established. Diazonamide A is a cytotoxic agent and Nmethylwelwitindolinone C isothiocyanate is a multidrug resistance (MDR) reversal agent. Only a vigorous synthetic program toward these natural products and selected derivatives will allow for their full examination both as biological agents for cell cycle study and as possible therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
-
批准号:6991230
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2003
-
负责人:Joseph Paul Konopelski
-
依托单位:
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
-
批准号:6832190
-
项目类别:
-
资助金额:$26.38万
-
财政年份:2003
-
负责人:Joseph Paul Konopelski
-
依托单位:
Cytotoxic & MDR-Active Alkaloids-Synthesis & Evaluation
-
批准号:6561727
-
项目类别:
-
资助金额:$29.05万
-
财政年份:2003
-
负责人:Joseph Paul Konopelski
-
依托单位:
NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS
-
批准号:3304402
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1990
-
负责人:Joseph Paul Konopelski
-
依托单位:
NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS
-
批准号:3304403
-
项目类别:
-
资助金额:$13.66万
-
财政年份:1990
-
负责人:Joseph Paul Konopelski
-
依托单位:
NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS
-
批准号:3304401
-
项目类别:
-
资助金额:$11.26万
-
财政年份:1990
-
负责人:Joseph Paul Konopelski
-
依托单位:
NOVEL ASYMMETRIC SYNTHESIS OF ANTI-AIDS COMPOUNDS
-
批准号:3304404
-
项目类别:
-
资助金额:$13.04万
-
财政年份:1990
-
负责人:Joseph Paul Konopelski
-
依托单位:
国内基金
海外基金
登录
查看更多内容
汉防己甲素协同维拉帕米靶向MDR-1/P-糖蛋白逆转T细胞多药耐药的药效及分子机制研究
-
批准号:JCZRLH202600483
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
基于MB-MDR分析模型的同型半胱氨酸代谢异常与动脉硬化多维度关联研究
-
批准号:2025JJ70491
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:谭碧峰
-
依托单位:
基于溶酶体逃逸增效构建GLUT1介导的级联靶向脂质体及其抗颅内
MDR-AB菌胞内感染研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:肖维
-
依托单位:
基于超分子自组装构建多途径逆转肿瘤MDR的靶向纳米递药体系用于增强抗癌疗效
-
批准号:22301246
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:晁爽
-
依托单位:
基于MDR-PTB病证生物学等多维动态数据联合多模态深度学习探索气阴虚证治规律
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:张顺先
-
依托单位:
MDR/Pre-XDR/XDR分枝杆菌的适应性代价和补偿性进化研究
-
批准号:2023JJ40007
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:皮锐
-
依托单位:
基于“调和寒热”理论构建逆转乳腺癌MDR的“寒性中药-光动力-光热”递药系统
-
批准号:82304908
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:任维
-
依托单位:
HnRNPK胞浆转位稳定MDR1mRNA参与胃癌细胞耐药的机制研究
-
批准号:2023JJ30521
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:曾颖
-
依托单位:
内生尤韦可拟盘多毛孢中新颖苯丙素苷类P-gp抑制剂的发现及其肿瘤MDR逆转机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:钱一鑫
-
依托单位:
LHBs对MDR1的调控及其在HBV转录、复制和肝细胞增殖转化中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:李世颖
-
依托单位: